The Role of Maintenance Oral Clofarabine in Older Adults With Acute Myeloid Leukemia
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the side effects of the study drug, clofarabine,
when given by mouth to patients with acute myeloid leukemia (AML), in remission.
Phase:
Phase 1
Details
Lead Sponsor:
Northwestern University
Collaborators:
Genzyme, a Sanofi Company Loyola University Rush University Medical Center University of Illinois at Chicago